Clinical Trial Update: Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ixekizumab delivery via auto-injector or prefilled syringe in adults with moderate to severe plaque psoriasis has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Ixekizumab (ixekizumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2016-05-26